Risk factor | AMI | HF | ||
---|---|---|---|---|
(No. 7613) | (No. 6348) | |||
No. | % | No. | % | |
Demographic characteristics | Â | Â | Â | Â |
Age (mean, SD) | 70.1* | 13.5* | 83.0* | 7.1* |
Gender (female) | 2690 | 35.3 | 4925 | 77.58 |
Previous conditions (from HIS) | Â | Â | Â | Â |
Cancer | 437 | 5.74 | Â | Â |
Diabetes | 829 | 10.89 | 406 | 6.4 |
Nutritional deficiencies | Â | Â | 18 | 0.28 |
Lipid metabolism disorders | 344 | 4.52 | Â | Â |
Obesity | 74 | 0.97 | 23 | 0.36 |
Blood disorders | 338 | 4.44 | 322 | 5.07 |
Dementia including Alzheimer’s disease |  |  | 192 | 3.02 |
Parkinson’s disease |  |  | 56 | 0.88 |
Hemiplegia and other paralytic syndromes | Â | Â | 22 | 0.35 |
Rheumatic heart disease | 67 | 0.88 | 30 | 0.47 |
Hypertension | 1382 | 18.15 | 877 | 13.82 |
Previous myocardial infarction | 1137 | 14.93 | 163 | 2.57 |
Other forms of ischemic heart diseases | 998 | 13.11 | 560 | 8.82 |
Acute endocarditis and myocarditis | 2 | 0.03 | Â | Â |
Cardiomyopathy | 95 | 1.25 | 50 | 0.79 |
Conduction disorders and arrhythmias | 592 | 7.78 | 479 | 7.55 |
Heart failure | 554 | 7.28 | 356 | 5.61 |
Ill-defined descriptions or complications of heart disease | 137 | 1.8 | 117 | 1.84 |
Other heart conditions | 103 | 1.35 | 82 | 1.29 |
Cerebrovascular disease | 512 | 6.73 | 561 | 8.84 |
Vascular disease | 304 | 3.99 | 154 | 2.43 |
Chronic obstructive pulmonary disease (COPD) | 423 | 5.56 | 366 | 5.77 |
Chronic diseases (liver, pancreas, intestine) | 85 | 1.12 | 71 | 1.12 |
Chronic renal disease | 419 | 5.5 | 232 | 3.65 |
Rheumatoid arthritis and other inflammatory polyarthropathies | Â | Â | 25 | 0.39 |
Osteoporosis and other disorders of bone and cartilage | Â | Â | 57 | 0.9 |
Previous coronary artery bypass graft | 310 | 4.07 | Â | Â |
Previous coronary angioplasty | 854 | 11.22 | Â | Â |
Cerebral revascularisation procedures | 42 | 0.55 | Â | Â |
Other cardiac operations | 47 | 0.62 | Â | Â |
Other vascular operations | 182 | 2.39 | Â | Â |
Clinical data (from the New Information System) | Â | Â | Â | Â |
Systolic blood pressure | Â | Â | Â | Â |
  ≤ 100 mmHg | 765 | 10.05 |  |  |
 >> 100 mmHg | 6592 | 86.59 |  |  |
  Missing | 256 | 3.36 |  |  |
International Normalised Ratio (INR) | Â | Â | Â | Â |
  0.9-1.2 |  |  | 4,834 | 76.15 |
  Out of range |  |  | 855 | 13.47 |
  Missing |  |  | 659 | 10.38 |
Drug prescriptionsa | Â | Â | Â | Â |
Anticoagulants | 493 | 6.48 | Â | Â |
Antiplatelet agents | 2447 | 32.14 | Â | Â |
Cardiac therapy drugs | 1686 | 22.15 | Â | Â |
Antihypertensive drugs | 359 | 4.72 | Â | Â |
Diuretics | 1577 | 20.71 | Â | Â |
Beta-blocking agents | 1554 | 20.41 | Â | Â |
Calcium channel blockers | 1570 | 20.62 | Â | Â |
ACE inhibitors | 1977 | 25.97 | Â | Â |
Angiotensin II antagonists | 1823 | 23.95 | Â | Â |
Statins | 1885 | 24.76 | Â | Â |
Other lipid-modifying agents | 557 | 7.32 | Â | Â |
Anti-diabetic drugs | 1614 | 21.2 | Â | Â |
Antiplatelet (3 months) |  |  | 851 | 13.41 |
Anticoagulants (3 months) |  |  | 238 | 3.75 |